Covered by insurance in all 50 states, incl. Medicare Advantage day one
Back to Blog

Lexapro for Anxiety: How Well It Works and What to Expect

Clinically reviewed by Daniel Montville, MD

Reviewed November 5, 2026 · Last updated November 5, 2026

Key Takeaways

  • Lexapro (escitalopram) is FDA-approved for generalized anxiety disorder in adults and children 7 and older. Use for social anxiety or panic disorder is off-label in the U.S., though trials support it.
  • In pooled data from three trials with about 850 adults, Lexapro improved anxiety more than placebo starting at week 1 or 2 and through week 8.
  • The usual starting dose is 10 mg once daily, with a maximum of 20 mg. In depression trials, 20 mg added side effects without clearly adding benefit.
  • Headache was the most frequently reported side effect in anxiety trials, while nausea, sleep changes, fatigue, and sexual side effects stood out most compared with placebo. Weight didn't differ meaningfully from placebo.
  • Staying on it after it works matters. In a relapse prevention trial, 56% of people switched to placebo relapsed, compared with 19% who continued Lexapro.

Maybe your mind has been running a background loop of worry for months, the kind that follows you to bed and greets you in the morning. Your prescriber mentioned Lexapro, and now you want to know what it does, how long it takes, and what it might cost you in side effects.

Your brain’s serotonin system is the signaling network that SSRIs target, and Lexapro (escitalopram) targets it with unusual precision. Its FDA label describes it as a highly selective serotonin reuptake inhibitor, with minimal effect on norepinephrine and dopamine reuptake and little affinity for other receptors.

The established approach to persistent anxiety is well defined. International anxiety treatment guidelines from the World Federation of Societies of Biological Psychiatry name SSRIs and SNRIs as first-line medications, and escitalopram has been tested in multiple placebo-controlled trials. The results are real.

But knowing a drug works on average doesn’t tell you how it will go for you, and at Siggy we’d rather walk you through the actual trial numbers than offer a reassuring summary.

This guide covers what Lexapro is approved for, how well it works, how long it takes, how dosing works, and which side effects are most likely. Every figure below comes from the FDA label or peer-reviewed trials, so you can weigh the evidence for yourself.

What This Page Covers

What Is Lexapro Approved to Treat?

Lexapro’s FDA label approves it for generalized anxiety disorder (GAD) in adults and children 7 and older, and for major depressive disorder in adults and adolescents 12 and older.

Escitalopram has also been studied for other anxiety disorders. In the U.S., using it for those conditions is off-label, meaning without a specific FDA approval for that condition. The evidence comes from the trials described below.

How Well Does Lexapro Work for Anxiety?

For GAD, the evidence is strong. The FDA label reports three 8-week trials in adults in which Lexapro improved anxiety scores more than placebo. Pooled trial results from those studies, covering about 850 adults, showed greater improvement with escitalopram from week 1 or 2 through week 8. People who stayed at 10 mg also improved more than those on placebo. The trials excluded people with major depression and other significant conditions, which limits how far the results generalize.

Escitalopram also holds up against other options. A Lancet network meta-analysis of 89 trials with 25,441 adults found duloxetine, pregabalin, venlafaxine, and escitalopram more effective than placebo for GAD, each with relatively good acceptability.

For other anxiety disorders, the evidence is smaller but supportive:

  • Social anxiety disorder: In a 12-week trial of 358 adults, 54% responded to escitalopram compared with 39% on placebo.
  • Panic disorder: In a 10-week trial of 366 adults, escitalopram reduced panic attack frequency more than placebo.

How Long Does Lexapro Take to Work?

Some people notice changes within the first one to two weeks, matching the pooled trial data. Escitalopram reaches steady levels in your blood within about a week of daily dosing, according to its label. Fuller benefit usually takes longer. The World Federation guidelines say anxiety medications in this class typically take two to four weeks to work, sometimes up to six, and recommend at least a four-week trial before changing course.

Side effects often show up before the relief does. For a week-by-week breakdown, see our guide to how long anxiety medication takes to work.

What Dose of Lexapro Is Used for Anxiety?

The label recommends starting at 10 mg once daily for GAD, taken morning or evening, with or without food. In adults, the dose can be raised to the 20 mg maximum after at least a week, and in children after at least two weeks. Older adults and people with liver impairment are generally kept at 10 mg.

More isn’t automatically better. In the label’s depression trials, 20 mg didn’t show a greater benefit than 10 mg. Side effects were reported by 66% of people on 10 mg and 61% on placebo, compared with 86% on 20 mg. Across anxiety disorders more broadly, a 2019 dose-response meta-analysis found higher SSRI doses linked to more improvement, along with more dropouts because of side effects. For how prescribers weigh that trade-off, see our guide to Lexapro dosing.

What Side Effects Are Most Common?

Side effects are often most noticeable in the first weeks. The figures below come from the placebo-controlled GAD trials in Lexapro’s prescribing information, with 429 adults taking Lexapro and 427 taking placebo.

Side Effect Lexapro Placebo
Headache 24% 17%
Nausea 18% 8%
Sleepiness 13% 7%
Insomnia 12% 6%
Fatigue 8% 2%
Delayed ejaculation (men) 14% 2%
Decreased libido 7% 2%

In those trials, 8% of people on Lexapro stopped because of side effects, compared with 4% on placebo. Anorgasmia affected 6% of women on Lexapro, compared with less than 1% on placebo. The label notes that sexual side effects are probably underreported, so it’s worth raising them directly. Weight change didn’t differ meaningfully from placebo in controlled trials. For more, see our guide to Lexapro side effects.

Who Should Be Cautious With Lexapro?

Lexapro is generally well tolerated, but the label flags important cautions:

  • People 24 and younger: Like all antidepressants, it carries a boxed warning for increased suicidal thoughts and behaviors in short-term studies of young people, so close monitoring matters early on and after dose changes.
  • Other medications: It must not be combined with MAOIs or pimozide, and other serotonergic drugs raise the risk of serotonin syndrome.
  • Bleeding risk: Taking it with NSAIDs, aspirin, or blood thinners can increase bleeding.
  • Older adults: Low sodium is more likely, so new confusion or unsteadiness should be reported.
  • Bipolar disorder: The label advises screening first, because antidepressants can trigger mania in people at risk.

If you’re pregnant or planning pregnancy, talk through the risks and benefits with your prescriber, since untreated symptoms carry risks too.

How Long Should You Stay on Lexapro?

Feeling better is a reason to keep going. In a relapse prevention trial, 375 adults whose GAD responded to 12 weeks of escitalopram were randomly assigned to continue it or switch to placebo. Over the following 24 to 76 weeks, 56% of the placebo group relapsed, compared with 19% of those who stayed on escitalopram.

The World Federation guidelines recommend continuing treatment for 6 to 12 months after symptoms resolve. When it’s time to stop, the label recommends a gradual taper. In the relapse trial, dizziness was the most common symptom during a tapered withdrawal, reported by 10% to 12% of people. Our guide on tapering off Lexapro explains what that process can look like.

If you have thoughts of harming yourself or feel unsafe, call or text 988. In an emergency, call 911. This article is for education only and isn’t a substitute for personal medical advice. It reflects sources available as of October 2026.

Start Your Anonymous Intake With Siggy

Lexapro helps many people with anxiety, but the right choice depends on your symptoms, your history, and what you’ve already tried. Start your anonymous intake with Siggy to describe your worry, sleep, and past medications in your own words, without giving your name or email. It’s free, and you’ll get a downloadable summary you can share with any clinician. Siggy’s licensed prescribers diagnose and treat the full range of mental health conditions, including anxiety. If an SSRI like Lexapro is part of the right plan, a licensed prescriber reviews your full clinical picture before anything is prescribed. If you’re weighing options, our comparison of Lexapro and Prozac lays out the key differences.

Mental healthcare should stay with you between appointments.

Siggy combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.

Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.

Start Anonymous Intake

Frequently Asked Questions

Does Lexapro work for anxiety?

It does for many people. Lexapro is FDA-approved for generalized anxiety disorder based on three 8-week trials in which it outperformed placebo. A network meta-analysis of 89 trials with 25,441 adults found escitalopram more effective than placebo for generalized anxiety disorder with relatively good acceptability. Not everyone responds, and some people need a different medication or added therapy.

How long does Lexapro take to work for anxiety?

Many people notice early changes within 1 to 2 weeks, with fuller benefit over several weeks. In pooled trial data, Lexapro separated from placebo starting at week 1 or 2. International guidelines note that anxiety medications like it usually take 2 to 4 weeks to work and recommend at least a 4-week trial before changing course.

What is the usual Lexapro dose for anxiety?

The FDA label recommends starting at 10 mg once daily for generalized anxiety disorder, with a maximum of 20 mg. In adults, the dose can be raised after at least 1 week, and in children 7 and older after at least 2 weeks. Older adults and people with liver impairment are generally kept at 10 mg.

What are the most common side effects of Lexapro?

In generalized anxiety disorder trials, headache was the most frequently reported side effect (24% vs 17% on placebo). The side effects that stood out most compared with placebo were nausea (18% vs 8%), sleepiness (13% vs 7%), insomnia (12% vs 6%), fatigue (8% vs 2%), and sexual side effects such as delayed ejaculation (14% vs 2% of men) and decreased libido (7% vs 2%). Weight change didn't differ meaningfully from placebo in controlled trials.

Can Lexapro be used for social anxiety or panic attacks?

It can, though that use is off-label in the U.S. In a 12-week trial of 358 adults with social anxiety disorder, 54% responded to escitalopram compared with 39% on placebo. In a 10-week panic disorder trial of 366 adults, escitalopram reduced panic attack frequency more than placebo.

What happens if I stop taking Lexapro?

Stopping raises the risk of anxiety returning, and stopping abruptly can cause discontinuation symptoms such as dizziness, irritability, and sensory disturbances. In a relapse prevention trial, 56% of people switched to placebo relapsed, compared with 19% who stayed on escitalopram. The FDA label recommends a gradual dose reduction rather than stopping suddenly.

Sources

  1. Allergan, Inc. Lexapro (escitalopram) prescribing information. DailyMed. dailymed.nlm.nih.gov
  2. Bandelow B, Allgulander C, Baldwin DS, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders, Version 3. Part I: Anxiety disorders. World Journal of Biological Psychiatry. 2023;24(2):79-117. doi:10.1080/15622975.2022.2086295
  3. Goodman WK, Bose A, Wang Q. Treatment of generalized anxiety disorder with escitalopram: pooled results from double-blind, placebo-controlled trials. Journal of Affective Disorders. 2005;87(2-3):161-167. doi:10.1016/j.jad.2004.11.011
  4. Slee A, Nazareth I, Bondaronek P, et al. Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis. Lancet. 2019;393(10173):768-777. doi:10.1016/S0140-6736(18)31793-8
  5. Kasper S, Stein DJ, Loft H, Nil R. Escitalopram in the treatment of social anxiety disorder: randomised, placebo-controlled, flexible-dosage study. British Journal of Psychiatry. 2005;186:222-226. doi:10.1192/bjp.186.3.222
  6. Stahl SM, Gergel I, Li D. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial. Journal of Clinical Psychiatry. 2003;64(11):1322-1327. doi:10.4088/jcp.v64n1107
  7. Jakubovski E, Johnson JA, Nasir M, Müller-Vahl K, Bloch MH. Systematic review and meta-analysis: dose-response curve of SSRIs and SNRIs in anxiety disorders. Depression and Anxiety. 2019;36(3):198-212. doi:10.1002/da.22854
  8. Allgulander C, Florea I, Huusom AKT. Prevention of relapse in generalized anxiety disorder by escitalopram treatment. International Journal of Neuropsychopharmacology. 2006;9(5):495-505. doi:10.1017/S1461145705005973